rs1872930
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_005989.4(AKR1D1):c.*36C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.788 in 1,605,206 control chromosomes in the GnomAD database, including 499,633 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.80 ( 48947 hom., cov: 32)
Exomes 𝑓: 0.79 ( 450686 hom. )
Consequence
AKR1D1
NM_005989.4 3_prime_UTR
NM_005989.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.67
Genes affected
AKR1D1 (HGNC:388): (aldo-keto reductase family 1 member D1) The enzyme encoded by this gene is responsible for the catalysis of the 5-beta-reduction of bile acid intermediates and steroid hormones carrying a delta(4)-3-one structure. Deficiency of this enzyme may contribute to hepatic dysfunction. Three transcript variants encoding different isoforms have been found for this gene. Other variants may be present, but their full-length natures have not been determined yet. [provided by RefSeq, Jul 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 7-138116698-C-T is Benign according to our data. Variant chr7-138116698-C-T is described in ClinVar as [Benign]. Clinvar id is 358956.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.858 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AKR1D1 | NM_005989.4 | c.*36C>T | 3_prime_UTR_variant | 9/9 | ENST00000242375.8 | NP_005980.1 | ||
AKR1D1 | NM_001190906.2 | c.*36C>T | 3_prime_UTR_variant | 8/8 | NP_001177835.1 | |||
AKR1D1 | NM_001190907.2 | c.*61C>T | 3_prime_UTR_variant | 8/8 | NP_001177836.1 | |||
AKR1D1 | XM_047420763.1 | c.*36C>T | 3_prime_UTR_variant | 8/8 | XP_047276719.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AKR1D1 | ENST00000242375.8 | c.*36C>T | 3_prime_UTR_variant | 9/9 | 1 | NM_005989.4 | ENSP00000242375 | P1 | ||
AKR1D1 | ENST00000411726.6 | c.*36C>T | 3_prime_UTR_variant | 8/8 | 2 | ENSP00000402374 | ||||
AKR1D1 | ENST00000432161.5 | c.*61C>T | 3_prime_UTR_variant | 8/8 | 2 | ENSP00000389197 | ||||
AKR1D1 | ENST00000468877.2 | n.1040C>T | non_coding_transcript_exon_variant | 10/10 | 2 |
Frequencies
GnomAD3 genomes AF: 0.800 AC: 121584AN: 152038Hom.: 48909 Cov.: 32
GnomAD3 genomes
AF:
AC:
121584
AN:
152038
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.769 AC: 193283AN: 251182Hom.: 74951 AF XY: 0.772 AC XY: 104855AN XY: 135776
GnomAD3 exomes
AF:
AC:
193283
AN:
251182
Hom.:
AF XY:
AC XY:
104855
AN XY:
135776
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.787 AC: 1142884AN: 1453050Hom.: 450686 Cov.: 29 AF XY: 0.787 AC XY: 568989AN XY: 723408
GnomAD4 exome
AF:
AC:
1142884
AN:
1453050
Hom.:
Cov.:
29
AF XY:
AC XY:
568989
AN XY:
723408
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.800 AC: 121677AN: 152156Hom.: 48947 Cov.: 32 AF XY: 0.797 AC XY: 59307AN XY: 74400
GnomAD4 genome
AF:
AC:
121677
AN:
152156
Hom.:
Cov.:
32
AF XY:
AC XY:
59307
AN XY:
74400
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2668
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 10, 2018 | This variant is associated with the following publications: (PMID: 23704699) - |
Congenital bile acid synthesis defect 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at